DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
06 07 2021
Historique:
received: 16 06 2021
revised: 29 06 2021
accepted: 01 07 2021
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 15 12 2021
Statut: epublish

Résumé

Although viruses infect various organs and are associated with diseases, there may be many unidentified pathogenic viruses. The recent development of next-generation sequencing technologies has facilitated the establishment of an environmental viral metagenomic approach targeting the intracellular viral genome. However, an efficient method for the detection of a viral genome derived from an RNA virus in animal or human samples has not been established. Here, we established a method for the efficient detection of RNA viruses in human clinical samples. We then tested the efficiency of the method compared to other conventional methods by using tissue samples collected from 57 recipients of living donor liver transplantations performed between June 2017 and February 2019 at Kyushu University Hospital. The viral read ratio in human clinical samples was higher by the new method than by the other conventional methods. In addition, the new method correctly identified viral RNA from liver tissues infected with hepatitis C virus. This new technique will be an effective tool for intracellular RNA virus surveillance in human clinical samples and may be useful for the detection of new RNA viruses associated with diseases.

Identifiants

pubmed: 34372516
pii: v13071310
doi: 10.3390/v13071310
pmc: PMC8309968
pii:
doi:

Substances chimiques

RNA, Double-Stranded 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Microbes Environ. 2015;30(2):199-203
pubmed: 26004793
MMWR Suppl. 2016 Jul 08;65(3):4-11
pubmed: 27389903
PLoS Pathog. 2016 Feb 22;12(2):e1005455
pubmed: 26901882
Nat Rev Microbiol. 2011 Feb;9(2):99-108
pubmed: 21200397
Viruses. 2021 May 17;13(5):
pubmed: 34067884
Elife. 2012 Nov 13;1:e00049
pubmed: 23150796
Virology. 2010 May 10;400(2):157-63
pubmed: 20172578
Nat Rev Microbiol. 2016 Aug;14(8):479-93
pubmed: 27396566
Nat Rev Microbiol. 2013 Feb;11(2):133-41
pubmed: 23268232
Cell. 2013 Feb 28;152(5):1173-83
pubmed: 23452860
Virology. 2009 May 10;387(2):395-401
pubmed: 19304303
Virology (Auckl). 2019 Jun 21;10:1178122X19849927
pubmed: 31258326
Nat Med. 2005 Jul;11(7):791-6
pubmed: 15951748
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4370-5
pubmed: 18334634
Hepatology. 2014 May;59(5):1726-37
pubmed: 24375637
Viruses. 2016 Mar 07;8(3):70
pubmed: 27072419
Virus Res. 2016 Jul 2;219:22-38
pubmed: 26546154
Am J Transplant. 2019 Feb;19 Suppl 2:184-283
pubmed: 30811890
Virology. 2018 Jan 15;514:57-65
pubmed: 29128757
J Virol. 2010 Jun;84(11):5824-35
pubmed: 20237083
J Gen Virol. 2019 Oct;100(10):1350-1362
pubmed: 31513008
Cell Rep. 2014 May 8;7(3):898-906
pubmed: 24767992
J Virol. 1996 May;70(5):2764-73
pubmed: 8627750
Nat Rev Microbiol. 2007 Feb;5(2):119-27
pubmed: 17224921
Mol Ecol Resour. 2018 Nov;18(6):1444-1455
pubmed: 30256532
Nat Rev Microbiol. 2007 Jun;5(6):453-63
pubmed: 17487147

Auteurs

Takuma Izumi (T)

Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 814-0180, Japan.

Yuhei Morioka (Y)

Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Syun-Ichi Urayama (SI)

Laboratory of Fungal Interaction and Molecular Biology (Donated by IFO), Department of Life and Environmental Sciences, University of Tsukuba, Ibaraki 305-8577, Japan.

Daisuke Motooka (D)

Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Tomokazu Tamura (T)

Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Takahiro Kawagishi (T)

Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Yuta Kanai (Y)

Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Takeshi Kobayashi (T)

Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Chikako Ono (C)

Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Akinari Morinaga (A)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 814-0180, Japan.

Takahiro Tomiyama (T)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 814-0180, Japan.

Norifumi Iseda (N)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 814-0180, Japan.

Yukiko Kosai (Y)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 814-0180, Japan.

Shoichi Inokuchi (S)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 814-0180, Japan.

Shota Nakamura (S)

Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Tomohisa Tanaka (T)

Department of Microbiology, Graduate School of Medical Science, Yamanashi University, Yamanashi 400-8510, Japan.

Kohji Moriishi (K)

Department of Microbiology, Graduate School of Medical Science, Yamanashi University, Yamanashi 400-8510, Japan.

Hiroaki Kariwa (H)

Laboratory of Public Health, Department of Preventive Veterinary Medicine, Division of Veterinary Medicine, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido 060-0808, Japan.

Tomoharu Yoshizumi (T)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 814-0180, Japan.

Masaki Mori (M)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 814-0180, Japan.

Yoshiharu Matsuura (Y)

Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Takasuke Fukuhara (T)

Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Hokkaido 060-0808, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH